December 7, 2021 – December 11, 2021

swoosh
swoosh

AGENDA

ENHANCE YOUR EXPERIENCE WITH MEDCHALLENGE!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

Callout Info for program

PART I

PART II

SESSION I

LEARNING OBJECTIVES

Upon completion of this activity, participants will have:

  • Increased knowledge regarding the:
    • Pathophysiologic mechanisms involved in schizophrenia 
    • Clinical data on new and emerging treatments for the management of schizophrenia 
    • Common tolerability issues associated with the use of antipsychotic medications 
    • Tardive dyskinesia (TD) and how to reduce its occurrence 
  • Greater competence related to :
    • Developing a treatment plan that reduces the occurrence of adverse events in patients receiving an antipsychotic therapy 

SESSION CO-CHAIRS


 

SESSION II

LEARNING OBJECTIVES

Upon completion of this activity, participants will have:

  • Increased knowledge regarding the:
    • Symptoms representative of the spectrum of bipolar disorder
    • Clinical data for therapies studied for the management of bipolar disorder
    • Factors that differentiate bipolar depression from unipolar depression
    • Clinical data on new and emerging treatments for the management of major depression
  • Greater competence related to :
    • Selection of appropriate therapies for the management of bipolar disorder
    • Timely and accurate recognition of depressive disorders
    • Development of a treatment plan for the management of treatment-resistant depression
    • Recognition of patients with bipolar disorder who have not responded adequately to treatment
    • Development of a treatment plan for bipolar disorder when established therapies are ineffective or poorly tolerated
    • Identification of substance abuse in patients with a co-morbid psychiatric disorder

SESSION CO-CHAIR


 

SESSION III

LEARNING OBJECTIVES

Upon completion of this activity, participants will have:

  • Increased knowledge regarding the:
    • Symptoms of psychosis in patients with Parkinson disease and dementia
    • Current understanding of the pathophysiology of autism
    • Clinical data on approaches to the management of autism
    • Clinical data on approaches to the management of ADHD
  • Greater competence related to :
    • Selecting an appropriate therapy for the management of psychosis in patients with Parkinson disease and dementia
    • Diagnosing patients with autism

SESSION CO-CHAIR


 

SESSION IV

LEARNING OBJECTIVES

Upon completion of this activity, participants will have:

  • Increased knowledge regarding the:
    • Role of sleep in daily function
    • Relationship between sleep disorders and psychiatric disorders
    • Recognition of symptoms associated with narcolepsy
  • Greater competence related to :
    • Selecting appropriate therapies for the management of insomnia
    • Personalizing the selection of therapies for the management of narcolepsy

SESSION CO-CHAIRS


 

SESSION V

LEARNING OBJECTIVES

Upon completion of this activity, participants will have:

  • Increased knowledge regarding the:
    • Clinical data for the use of neuromodulatory devices for the management of psychiatric disorders
    • The role of digital tools for the recognition of psychiatric disorders
    • The role of digital therapeutics in psychiatric disorders
    • Clinical data on pharmacogenomic considerations for the management of psychiatric disorders
    • Technologies available to help patients access care

SESSION CO-CHAIRS


 

SESSION VI

LEARNING OBJECTIVES

Upon completion of this session, learners will have

  • Increased knowledge regarding
    • add or remove
  • Greater competence related to
    • add or remove

FACULTY


 

ENHANCE YOUR EXPERIENCE WITH MEDCHALLENGE!